These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32160643)

  • 1. Influence of Tranexamic Acid on Inflammatory Signaling in Trauma.
    Barrett CD; Kong YW; Yaffe MB
    Semin Thromb Hemost; 2020 Mar; 46(2):183-188. PubMed ID: 32160643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
    Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid: Beyond antifibrinolysis.
    Prudovsky I; Kacer D; Zucco VV; Palmeri M; Falank C; Kramer R; Carter D; Rappold J
    Transfusion; 2022 Aug; 62 Suppl 1():S301-S312. PubMed ID: 35834488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.
    McCormack PL
    Drugs; 2012 Mar; 72(5):585-617. PubMed ID: 22397329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis and tranexamic acid: mechanistic principles.
    Draxler DF; Medcalf RL
    ANZ J Surg; 2020 Apr; 90(4):410-411. PubMed ID: 32339417
    [No Abstract]   [Full Text] [Related]  

  • 7. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
    Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological mechanisms and individual variation in fibrinolysis after major trauma.
    Coats TJ; Morsy M
    Emerg Med J; 2020 Mar; 37(3):135-140. PubMed ID: 32001608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 11. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro.
    Yee BE; Wissler RN; Zanghi CN; Feng C; Eaton MP
    Anesth Analg; 2013 Oct; 117(4):767-772. PubMed ID: 24023015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model.
    Campos Nogueira YA; Gomes da Costa LN; Levy CE; Orsi FA; de Lima F; Annichinno-Bizzacchi JM; De Paula EV
    PLoS One; 2019; 14(12):e0226871. PubMed ID: 31891611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.
    Draxler DF; Daglas M; Fernando A; Hanafi G; McCutcheon F; Ho H; Galle A; Gregory J; Larsson P; Keragala C; Wright DK; Tavancheh E; Au AE; Niego B; Wilson K; Plebanski M; Sashindranath M; Medcalf RL
    J Thromb Haemost; 2019 Dec; 17(12):2174-2187. PubMed ID: 31393041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most?
    Cole E; Davenport R
    Int Emerg Nurs; 2015 Jan; 23(1):38-41. PubMed ID: 24776457
    [No Abstract]   [Full Text] [Related]  

  • 15. Tranexamic acid prolongs survival after controlled hemorrhage in rats.
    Roy M; Burggraf M; Lendemans S; de Groot H; Rohrig R
    J Surg Res; 2017 Feb; 208():104-110. PubMed ID: 27993197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tranexamic acid in pediatric trauma patients: Evidence from meta-analysis.
    Al-Jeabory M; Gasecka A; Wieczorek W; Mayer-Szary J; Jaguszewski MJ; Szarpak L
    Am J Emerg Med; 2021 Nov; 49():404-405. PubMed ID: 33722435
    [No Abstract]   [Full Text] [Related]  

  • 17. Tranexamic acid for trauma-related hemorrhage.
    Bailey AM; Baker SN; Weant KA
    Adv Emerg Nurs J; 2014; 36(2):123-31; quiz 132-3. PubMed ID: 24785665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography.
    De Souza RL; Short T; Warman GR; Maclennan N; Young Y
    Anaesth Intensive Care; 2004 Aug; 32(4):580-7. PubMed ID: 15675222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basis of antifibrinolytic therapy.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():35-40. PubMed ID: 6159375
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytics for heavy menstrual bleeding.
    Lethaby A; Farquhar C; Cooke I
    Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.